Impact of Primary Site Surgery on Survival of Patients with de novo Stage IV Breast Cancer

References

• DeSantis CE, Ma J, Gaudet MM, et al. Breast cancer statistics, 2019. CA Cancer J Clin. 2019;69(6):438–451. doi:10.3322/caac.2158331577379
   PubMed Web of Science ®Google Scholar
• Tyagi NK, Dhesy-Thind S. Clinical practice guidelines in breast cancer. Curr Oncol. 2018;25(Suppl 1):S151–S160. doi:10.3747/co.25.372929910658
   PubMed Web of Science ®Google Scholar
• Soran A, Ozmen V, Ozbas S, et al. Randomized trial comparing resection of primary tumor with no surgery in stage iv breast cancer at presentation: protocol MF07-01. Ann Surg Oncol. 2018;25(11):3141–3149. doi:10.1245/s10434-018-6494-629777404
   PubMed Web of Science ®Google Scholar
• King TA, Lyman JP, Gonen M. Prognostic impact of 21-gene recurrence score in patients with stage iv breast cancer: TBCRC 013. J Clin Oncol. 2016;34(20):2359–2365. doi:10.1200/JCO.2015.63.196027001590
   PubMed Web of Science ®Google Scholar
• Santa-Maria CA, Gradishar WJ. Changing treatment paradigms in metastatic breast cancer: lessons learned. JAMA Oncol. 2015;1(4):528–534. doi:10.1001/jamaoncol.2015.119826181262
   PubMed Web of Science ®Google Scholar
• Bleicher RJ, Ruth K, Sigurdson ER, et al. Time to surgery and breast cancer survival in the United States. JAMA Oncol. 2016;2(3):330–339. doi:10.1001/jamaoncol.2015.450826659430
   PubMed Web of Science ®Google Scholar
• Xiong Z, Deng G, Wang J, et al. Could local surgery improve survival in de novo stage IV breast cancer? BMC Cancer. 2018;18(1):885. doi:10.1186/s12885-018-4767-x30200932
   PubMed Web of Science ®Google Scholar
• Wang W, Liu J, Wang J, Gao J, Wang X, Wang X. Impact of locoregional treatment on prognosis of de novo stage iv breast cancer: a retrospective long-term study of chinese population. Gynecol Obstet Invest. 2019;84(3):248–258. doi:10.1159/00048864330448829
   PubMed Web of Science ®Google Scholar
• Desille-Gbaguidi H, Avigdor S, Body G, Ouldamer L. Survival impact of primary site surgery on metastatic breast cancer patients at diagnosis. J Gynecol Obstet Hum Reprod. 2019;48(3):171–177. doi:10.1016/j.jogoh.2018.10.01430352310
   PubMed Web of Science ®Google Scholar
• Leung AM, Vu HN, Nguyen KA, Thacker LR, Bear HD. Effects of surgical excision on survival of patients with stage IV breast cancer. J Surg Res. 2010;161(1):83–88. doi:10.1016/j.jss.2008.12.03019375721
   PubMed Web of Science ®Google Scholar
• Bafford AC, Burstein HJ, Barkley CR, et al. Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival. Breast Cancer Res Treat. 2009;115(1):7–12. doi:10.1007/s10549-008-0101-718581232
   PubMed Web of Science ®Google Scholar
• Badwe R, Hawaldar R, Nair N, et al. Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial. Lancet Oncol. 2015;16(13):1380–1388. doi:10.1016/S1470-2045(15)00135-726363985
   PubMed Web of Science ®Google Scholar
• Ren Z, Li Y, Hameed O, Siegal GP, Wei S. Prognostic factors in patients with metastatic breast cancer at the time of diagnosis. Pathol Res Pract. 2014;210(5):301–306. doi:10.1016/j.prp.2014.01.00824635972
   PubMed Web of Science ®Google Scholar
• Ranji P, Salmani Kesejini T, Saeedikhoo S, Alizadeh AM. Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance. Tumour Biol. 2016;37(10):13059–13075. doi:10.1007/s13277-016-5294-527561758
   PubMedGoogle Scholar
• Kim MY, Oskarsson T, Acharyya S, et al. Tumor self-seeding by circulating cancer cells. Cell. 2009;139(7):1315–1326. doi:10.1016/j.cell.2009.11.02520064377
   PubMed Web of Science ®Google Scholar
• Rashid OM, Nagahashi M, Ramachandran S, et al. Resection of the primary tumor improves survival in metastatic breast cancer by reducing overall tumor burden. Surgery. 2013;153(6):771–778. doi:10.1016/j.surg.2013.02.00223489938
   PubMed Web of Science ®Google Scholar
• Khan SA, Stewart AK, Morrow M. Does aggressive local therapy improve survival in metastatic breast cancer? Surgery. 2002;132(4):620–626. doi:10.1067/msy.2002.12754412407345
   PubMed Web of Science ®Google Scholar
• Gnerlich J, Jeffe DB, Deshpande AD, Beers C, Zander C, Margenthaler JA. Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988–2003 SEER data. Ann Surg Oncol. 2007;14(8):2187–2194. doi:10.1245/s10434-007-9438-017522944
   PubMed Web of Science ®Google Scholar
• Blanchard DK, Shetty PB, Hilsenbeck SG, Elledge RM. Association of surgery with improved survival in stage IV breast cancer patients. Ann Surg. 2008;247(5):732–738. doi:10.1097/SLA.0b013e3181656d3218438108
   PubMed Web of Science ®Google Scholar
• Choi SH, Kim JW, Choi J, et al. Locoregional treatment of the primary tumor in patients with de novo stage iv breast cancer: a radiation oncologist’s perspective. Clin Breast Cancer. 2018;18(2):e167–e178. doi:10.1016/j.clbc.2017.06.00228689012
   PubMed Web of Science ®Google Scholar
• Pece S, Disalvatore D, Tosoni D, et al. Identification and clinical validation of a multigene assay that interrogates the biology of cancer stem cells and predicts metastasis in breast cancer: a retrospective consecutive study. EBioMedicine. 2019;42:352–362. doi:10.1016/j.ebiom.2019.02.03630846393
   PubMed Web of Science ®Google Scholar
• Daly B, Olopade OI. A perfect storm: how tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change. CA Cancer J Clin. 2015;65(3):221–238. doi:10.3322/caac.2127125960198
   PubMed Web of Science ®Google Scholar
• Xiong Z, Deng G, Huang X, et al. Bone metastasis pattern in initial metastatic breast cancer: a population-based study. Cancer Manag Res. 2018;10:287–295. doi:10.2147/CMAR.S15552429467583
   PubMed Web of Science ®Google Scholar
• Briasoulis E, Karavasilis V, Kostadima L, Ignatiadis M, Fountzilas G, Pavlidis N. Metastatic breast carcinoma confined to bone: portrait of a clinical entity. Cancer. 2004;101(7):1524–1528. doi:10.1002/cncr.2054515316943
   PubMed Web of Science ®Google Scholar
• Neuman HB, Morrogh M, Gonen M, Van Zee KJ, Morrow M, King TA. Stage IV breast cancer in the era of targeted therapy: does surgery of the primary tumor matter? Cancer. 2010;116(5):1226–1233. doi:10.1002/cncr.2487320101736
   PubMed Web of Science ®Google Scholar
• Cady B, Nathan NR, Michaelson JS, Golshan M, Smith BL. Matched pair analyses of stage IV breast cancer with or without resection of primary breast site. Ann Surg Oncol. 2008;15(12):3384–3395. doi:10.1245/s10434-008-0085-x18726129
   PubMed Web of Science ®Google Scholar